Similar articles

• Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart.

  Löbel P, Schrör K. Löbel P, et al. Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):125-30. doi: 10.1007/BF00634228. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 3937058
• Acceleration of endogeneous PGI2 generation from isolated rat aortae by MK-447.

  Harada Y, Tanaka K, Katori M. Harada Y, et al. Jpn J Pharmacol. 1981 Oct;31(5):845-8. doi: 10.1254/jjp.31.845. Jpn J Pharmacol. 1981. PMID: 6796739 No abstract available.
• Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin.

  Niada R, Mantovani M, Prino G, Pescador R, Berti F, Omini C, Folco GC. Niada R, et al. Thromb Res. 1981 Aug 1;23(3):233-46. doi: 10.1016/0049-3848(81)90013-x. Thromb Res. 1981. PMID: 7029778 No abstract available.
• Prostaglandins and platelets.

  Mustard JF, Kinlough-Rathbone RL, Packham MA. Mustard JF, et al. Annu Rev Med. 1980;31:89-96. doi: 10.1146/annurev.me.31.020180.000513. Annu Rev Med. 1980. PMID: 6994628 Review.
• The problems and the promise of prostaglandin influences in atherogenesis.

  Moncada S, Radomski MW. Moncada S, et al. Ann N Y Acad Sci. 1985;454:121-30. doi: 10.1111/j.1749-6632.1985.tb11850.x. Ann N Y Acad Sci. 1985. PMID: 3935029 Review. No abstract available.